- Home
- PEBK vs NVCT Comparison
PEBK vs NVCT Comparison
Compare PEBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- NVCT
- Stock Information
- Founded
- PEBK 1912
- NVCT 2020
- Country
- PEBK United States
- NVCT United States
- Employees
- PEBK N/A
- NVCT N/A
- Industry
- PEBK Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- PEBK Finance
- NVCT Health Care
- Exchange
- PEBK Nasdaq
- NVCT Nasdaq
- Market Cap
- PEBK 155.1M
- NVCT 152.3M
- IPO Year
- PEBK N/A
- NVCT 2022
- Fundamental
- Price
- PEBK $30.50
- NVCT $6.43
- Analyst Decision
- PEBK
- NVCT Strong Buy
- Analyst Count
- PEBK 0
- NVCT 3
- Target Price
- PEBK N/A
- NVCT $15.33
- AVG Volume (30 Days)
- PEBK 7.2K
- NVCT 233.1K
- Earning Date
- PEBK 07-21-2025
- NVCT 08-05-2025
- Dividend Yield
- PEBK 3.16%
- NVCT N/A
- EPS Growth
- PEBK 4.77
- NVCT N/A
- EPS
- PEBK 3.11
- NVCT N/A
- Revenue
- PEBK $84,131,000.00
- NVCT N/A
- Revenue This Year
- PEBK N/A
- NVCT N/A
- Revenue Next Year
- PEBK N/A
- NVCT N/A
- P/E Ratio
- PEBK $9.92
- NVCT N/A
- Revenue Growth
- PEBK 6.23
- NVCT N/A
- 52 Week Low
- PEBK $23.74
- NVCT $4.44
- 52 Week High
- PEBK $33.31
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- PEBK 65.38
- NVCT 39.18
- Support Level
- PEBK $27.71
- NVCT $5.85
- Resistance Level
- PEBK $28.50
- NVCT $6.99
- Average True Range (ATR)
- PEBK 0.76
- NVCT 0.51
- MACD
- PEBK 0.14
- NVCT -0.04
- Stochastic Oscillator
- PEBK 100.00
- NVCT 27.62
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.